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The expression of proliferation-dependent antigens during the lifespan of
normal and progeroid human fibroblasts in culture
Ian R. Kill1, Richard G. A. Faragher2, Kay Lawrence1 and Sydney Shall2
1Department of Biological Sciences, The University, Dundee DD1 4HN, UK
2Laboratory of Cell and Molecular Biology, Biology Building, University of Sussex, Brighton BN1 9QG, UKNormal human fibroblasts display a limited lifespan in
culture, which is due to a steadily decreasing fraction of
cells that are able to proliferate. Using antibodies that react
with antigens present in proliferating cells only, in an
indirect immunofluorescence assay, we have estimated the
fraction of proliferating cells in cultures of normal human
fibroblasts. Furthermore, we have estimated the rate of
decline in the fraction of proliferating cells during the
process of cellular ageing by application of the assay to
normal human fibroblasts throughout their lifespan in
culture. Werner’s Syndrome is an autosomal recessive
disease in which individuals display symptoms of ageing
prematurely. Werner’s Syndrome fibroblasts display a
reduced lifespan in culture compared with normal human
fibroblasts. Like normal human fibroblasts, the growth of
Werner’s Syndrome fibroblasts is characterised by a
decreasing fraction of cells reacting with the proliferation-
associated antibodies throughout their lifespan in culture.
However, the rate of loss of proliferating cells in Werner’s
Syndrome fibroblasts during the process of cellular ageing
is accelerated 5- to 6-fold compared with the rate deter-
mined for normal human fibroblasts.
Key words: cellular ageing, proliferation assay, Werner’s syndrome,
human fibroblast, cell mortalization
SUMMARYINTRODUCTION
The growth of normal human fibroblasts is characterised by a
finite and predictable lifespan (Hayflick and Moorhead, 1961;
Shall, 1987). The limited lifespan is due to a steadily decreas-
ing fraction of cells that are able to proliferate (Cristofalo and
Sharf, 1973; Smith and Hayflick, 1974; Westermark, 1978;
Stein et al., 1978; Shall and Stein, 1979; Ponten et al., 1983).
Cultures of normal human fibroblasts have been widely used
both as a model for ageing in vitro and as an example of cell
growth regulation.
Werner’s Syndrome (WS) is a rare autosomal recessive
disease in which the affected patients display symptoms of
ageing prematurely. Individuals suffering from WS may
exhibit a number of a wide range of symptoms including short
stature, hypogonadism, juvenile cataracts, premature greying
of hair with alopecia, diabetes, atherosclerosis, skin changes
and osteoporosis. However, individuals do not usually suffer
the behavioral changes and Alzheimer-type neuropathologies
commonly associated with old age. Diagnosis of WS therefore
relies upon assessment of a number of criteria. All WS indi-
viduals appear to display two additional diagnostic features:
firstly, affected individuals display increased levels of urinary
hyaluronic acid; secondly, fibroblasts derived from affected
individuals display a markedly reduced in vitro lifespan
compared with normal fibroblasts (Epstein et al., 1966; Tollefs-
bol and Cohen, 1984). Since only a single Mendelian genetic
locus is involved, it is likely that the mechanisms responsiblefor the shorter lifespan of WS fibroblasts in culture are related
to the mechanisms causing the onset of premature ageing in
individuals. Therefore, a comparison of the behaviour of
normal and WS fibroblasts in vitro may provide insight into
the processes involved in ageing in vivo. The relative rates of
ageing (loss of proliferative potential) of normal and WS
fibroblasts in culture are unknown. In order to compare the pro-
liferative behaviour of normal and WS fibroblasts it is
necessary to determine the population ‘age’ of cultures and to
determine how this ‘age’ varies with passage.
Two parameters are needed to identify a meaningful bio-
logical age of cells in culture; the number of cell generations
the culture has survived and the fraction of cells in the culture
that are still capable of proliferation. Passage number and accu-
mulated population doublings achieved, provide only a very
rough estimate of the progress of cell cultures. The most
commonly used method to determine the population ‘age’ of
cultures has been to estimate by autoradiography the fraction
of cells incorporating radioactive nucleosides after a long
exposure (Cristofalo and Sharf, 1973). The estimates obtained
could then be compared with previous estimates made at each
passage level, and from this an estimate of the population age
could be deduced. This method has been cogently criticised by
Macieira-Coelho (1974), because it is acutely dependent upon
unknown factors like the duration of the cell cycle phases and
the variances of their distributions. This method is very
sensitive to the period used for labelling compared to the cell
cycle phases; too short a label fails to reveal all cycling cells,
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Fig. 1. Growth characteristics of the normal human fibroblast cell
strain 1Br.3. (A) Growth curve for the human diploid cell strain
1Br.3. (B) Number of population doublings achieved at the indicated
passage levels for the human dermal fibroblast cell strain 1Br.3.
A
Bwhile too long a label overestimates cycling cells because some
of the labelled cells divide and are counted twice.
Immunohistochemical markers of cellular proliferation
have been widely used to analyze the proportion of prolifer-
ating cells in histological sections of tumours (Hall and
Woods, 1990). We present here a simple, reliable method for
the determination of the population age of cultures of human
cells. The method is based upon the estimation of the fraction
of human fibroblasts expressing a number of antigens
commonly associated with proliferation, in an indirect
immunofluorescence assay performed at each passage level.
In addition, we have estimated the fractions of cells express-
ing a number of antigens that are expressed independently of
the cell cycle in a similar assay performed at each passage
level, and these serve as a control for the total metabolising
population of cells.
The results we have obtained indicate that there is a smooth
and progressive decline in the fraction of cells expressing each
of the cell cycle-dependent antigens, whilst the fraction of cells
expressing each of the cell cycle-independent antigens remains
constant and high throughout the in vitro ageing process.
Thus, estimation of the fraction of cells expressing the cell
cycle-dependent antigens throughout the lifespan of a culture
provides a useful means for the estimation of the population
age of mortal human cultures. 
When a similar indirect immunofluorescence assay was
applied to cultures of WS fibroblasts, we found that as with
normal fibroblasts there was a smooth decline in the fraction
of cells displaying the proliferation-dependent antigens.
However, in the case of WS fibroblasts the rate of decline in
the fraction of proliferating cells was accelerated by between
5- and 6-fold compared with normal fibroblasts.
MATERIALS AND METHODS
Cells and cultures
Human dermal fibroblasts (Strain 1BR.3) were obtained by punch
biopsy from a 23-year-old male and have been described previously
(Arlett et al., 1975). Mass cultures were grown in 90 mm dishes
(Gibco/Nunc) in Dulbecco’s modification of Eagle’s medium
(DMEM) supplemented with 10% (v/v) newborn calf serum (NCS)
and antibiotics (10 units ml- 1 penicillin and 50 m g ml- 1 streptomycin)
at 37°C in a 5% CO2 atmosphere. Cells were released from the dish
every 3 or 4 days by incubation with 0.01% (w/v) trypsin and 0.02%
(w/v) EDTA, counted in an haemacytometer and replated into fresh
dishes at a density of 3· 103 cells cm- 2. This procedure was carried
out until fewer cells were obtained upon subculture than were seeded.
Accumulated population doublings (APD) were calculated from the
increase in cell numbers in successive passages.
WS fibroblasts (strain BJ846) were obtained from a skin punch
biopsy from a 24-year-old male patient initially diagnosed as a mute,
hypogonadial dwarf. The patient was subsequently diagnosed as
suffering from Werners Syndrome. Cultures were prepared, passaged
and maintained as described for normal fibroblasts above.
Fibroblast cultures were made quiescent by washing twice in
serum-free medium followed by incubation in medium supplemented
with 0.5% (v/v) NCS for two days.
Antibodies
All antibody solutions were diluted in PBS containing 1% (v/v) NCS.
Anti-Ki-67 (Dako PC, Denmark) was used at 1:25; anti-PCNA (anti-
proliferating cell nuclear antigen, a kind gift from Dr R. Bravo, Hei-delberg) was used at 1:1000; anti-topo II (anti-topoisomerase II, a
kind gift from Dr L. Lui, Baltimore) was used at 1:250; SCL 70 (anti-
topoisomerase I) and AAC 14 (anti-nucleolar antigens), were obtained
from PRU Antiserum Purchasing Unit, Protein Reference Unit, Royal
Hallasham Hospital, Sheffield S10 2JF) and both used at 1:500 and
L68A7 (anti-lamin A/C, a kind gift from Dr R. Stick, Tubingen) was
used at 1:500. Fluorochrome-conjugated second antibodies (Dako,
Denmark) were used as follows: fluorescein-conjugated rabbit anti-
mouse, 1:20 (anti-Ki-67, L68A7); rhodamine-conjugated goat anti-
human, 1:25 (anti-PCNA, SCL 70, AAC 14) and fluorescein-conju-
gated goat anti-rabbit, 1:40 (anti-topo II).
Description of the antibodies
Antibodies reacting with proliferation-dependent antigens: anti-Ki-
67, anti-PCNA and anti-topo II. Antibodies reacting with prolifera-
tion-independent antigens: AAC 14 (anti-nucleolar antigens), L68A7
(anti-A/C-type lamins), SCL 70 (anti-DNA topoisomerase I)
Anti-Ki-67 is a monoclonal antibody that reacts with nuclear
antigens expressed in proliferating cells only (Gerdes et al., 1983,
1984, 1991).
Proliferating cell nuclear antigen (PCNA) was initially identified as
a nuclear autoantigen from patients with systemic lupus erythemato-
sus (Miyachi et al., 1978), and has subsequently been shown to be an
auxiliary protein of DNA polymerase delta (Bravo et al., 1987; Prelich
et al., 1987).
Topoisomerase II (topo II) is a well characterised nuclear enzyme
involved in both DNA replication (Yang et al., 1987), and the segre-
573Proliferation in normal and progeroid fibroblasts
Fig. 2. Indirect immunofluorescence staining patterns obtained using the antibodies (A) anti-Ki-67, (B) anti-PCNA, (C) anti-topoisomerase II,
(G) AAC 14, anti-nucleolar, (H) SCL 70, anti-topoisomerase I and (I) L6 8A7, anti lamin A/C. The identical fields are stained with DAPI to
reveal DNA (D-F, and J-K) All photomicrographs were taken at the same magnification. Bar, 20 m m.gation of replicated DNA molecules (DiNardo et al., 1984; Uemura
and Yanagida, 1984; Earnshaw and Heck, 1985).
AAC14 is an antibody present in the serum of a human patient
suffering from an autoimmune disease. The antibody recognises
nucleolar antigens.
The nuclear lamins are a group of polypeptides that form a
meshwork of intermediate filaments contiguous with the inner surface
of the nuclear membrane (reviewed by Cox and Hutchison, 1993).
The lamins are present in the nucleus throughout interphase although
immunolocalisation studies have demonstrated cell-cycle-dependent
patterns of distribution (Bridger et al., 1993).
Topo I has been shown to regulate the superhelical density of DNA
by transiently nicking one strand on the DNA helix (Wang, 1985).
The relative level of expression of topo I compared with total cellular
protein has been demonstrated to remain essentially constant as cells
progress through the cell cycle, and is thus regulated independently
of the cell cycle (Heck et al., 1988).Indirect immunofluorescence
Cells were plated onto glass coverslips at the same density as used for
the mass cultures. On the day of subcultivation of the mass cultures,
the cells on coverslips were washed extensively with Ca2+- and Mg2+-
free phosphate buffered saline (PBS) and fixed with methanol/acetone
(1:1 v/v) at 4°C for 10 minutes, rehydrated in PBS and incubated with
10 m l of antibody solutions at the dilutions given above, for 1 hour at
room temperature in an humidified atmosphere. After washing with
PBS the cells were covered with 10 m l of second antibody solutions
for 1 hour at room temperature in an humidified atmosphere then
washed with PBS and mounted on glass slides in 50% (v/v) glycerol
in 50 mM Tris-HCl (pH 8.0) containing 1 m g/ml 4,6-diamidino-2-
phenylindole and 1 mg/ml p-phenylenediamine and sealed with nail
polish. Stained cells were viewed with a Zeiss Photomicroscope III
fitted with a · 60 water-immersion objective using epifluorescence. For
assessment of the proportion of stained cells, 1000 total or 200 positive
nuclei, whichever came first, were counted in randomly selected fields.
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Fig. 3. The distribution of Ki-67 during interphase and
mitosis. Immunolocalisation of Ki-67 in normal human
fibroblasts during interphase: (A) shows the
distribution of DNA, revealed by DAPI staining, (C)
shows the distribution of Ki-67 and (E) shows the same
field viewed using Nomarski optics. Arrowheads
indicate the association of Ki-67 with components of
the nucleoli. Immunolocalisation of Ki-67 during
mitosis: (B) shows the distribution of DNA, (D) shows
the distribution of Ki-67 and (F) shows the same field
viewed using Nomarski optics indicating that nuclear
envelope breakdown has occurred. Bar, 10 m m.RESULTS
Growth of normal human dermal fibroblasts
The complete lifespan growth curve for the cell strain 1BR.3
is shown in Fig. 1A. Regular twice-weekly passaging was used
to maintain the cells in log-phase growth, thereby minimising
proliferative decline due to topoinhibition. The culture was
passaged 27 times over 120 days, having undergone some 65
APD, before no increase in cell number was observed after 7
days. This result is consistent with those obtained with other
human fibroblast cell strains (Hayflick, 1965; Martin et al.,
1970; Cristofalo and Sharf, 1973; Ponten et al., 1983). Early
passage cultures (passages 1-6) were unavailable, the growth
curve for this period being supplied by Dr C. Arlett, Univer-
sity of Sussex. Even this presentation of the data shows a
gradually declining growth rate from the outset of the culture.
The decline in growth rate is clearly seen when the growth
achieved at each passage is shown graphically (Fig. 1B).
Indirect immunofluorescence of the antigens
Representative photomicrographs of the staining patterns
obtained with each antibody are shown in Fig. 2A-C and G-I.
Cells were also stained with DAPI to reveal the distribution of
DNA and thus to visualise all the cells in each field (Fig. 2D-
F and J-L). 
Staining for Ki-67 under the conditions reported here gave
reasonable discrimination between positive and negative
nuclei, although variation in intensity and staining pattern wasobserved between positive nuclei (Fig. 2A,D). Since the
majority of studies involving immunolocalisation of the Ki-67
antigen have been performed in transformed cell lines, it was
necessary to determine whether the Ki-67 antigen behaved in
a similar manner in normal fibroblasts (Fig. 3). During inter-
phase the Ki-67 antigen seems to be associated with several
discrete nuclear structures (Fig. 3A,C and E, arrows) and is not
uniformly dispersed through the nucleus. The nuclear struc-
tures with which Ki-67 associates have been identified as
nucleoli (Verheijen et al., 1989a,b). In contrast, during mitosis
the Ki-67 antigen is clearly associated with condensing chro-
mosomes and not with the mitotic spindle (Fig. 3B,D and F).
Thus, we conclude that the Ki-67 antigen does behave in a
similar manner in normal fibroblasts and in transformed cells.
Staining for PCNA following fixation by methanol/acetone
gave a bright punctate pattern, easily discernable from nega-
tively stained nuclei (Fig. 2B,E). This method of fixation and
staining with antibodies to PCNA has been shown to reveal
sites of active DNA synthesis (Bravo and Macdonald-Bravo,
1987) and thus represents S phase nuclei.
All cells showed a positive reaction with the antibody to topo
II, however, a fraction of nuclei displaying a diffuse bright stain
were apparent, and it is these nuclei that are used as the data
presented here as topo II-positive (Fig. 2C,F). During cell cycle
progression, nucleoli undergo characteristic re-organisations
(Ghosh, 1987). Immediately following mitosis nucleoli are
present as a number of small foci that coalesce during G1 to
form larger aggregates. Co-staining of fibroblasts with topo II




Fig. 4. The fraction of nuclei reacting with the antibodies anti-Ki-67, anti-PCNA and anti-topo II during cellular ageing of the normal fibroblast
cell strain 1Br.3. The fractions of nuclei reacting with the indicated antibodies were plotted as a function of passage (A,B and C), and
accumulated population doublings (APD; D,E and F). Regression lines were fitted using the method of least squares, and the details of the fitted
lines are given in Table 1.and anti-nucleolar antibodies have revealed that the diffuse
bright topo II stain correlates with cells that have passed through
mitosis and are in the process of nuclear reformation (I. R. Kill,
J. M. Bridger and C. T. Hutchison, unpublished data).
The staining patterns obtained using both AAC14 (anti-
nucleolar antigens, Fig. 2G,J) and SCL 70 (anti-topo I, Fig.
2H,K) were similar, being largely restricted to large, discrete
regions present in the nucleus. Staining for L68A7 (anti-
nuclear lamins, Fig. 2I,L) revealed intense staining of the
nuclear rim.The fraction of cells displaying the antigens during
ageing of normal human dermal fibroblasts in
culture
The fraction of cells that display each of the antigens Ki-67,
PCNA and topo II as the cultures age show a smooth decline
(Fig. 4A,B and C). The anti-Ki-67 antibody is thought to detect
all proliferating cells whilst anti-PCNA detects only S-phase
cells; thus, we observe that at any given point during the
lifespan, the fraction of cells reacting with anti-Ki-67 antibod-
ies is greater than the fraction of cells reacting with anti-PCNA.
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Fig. 5. Growth characteristics of the Werner’s Syndrome fibroblast
cell strain BJ846. (A) Growth curve for the WS cell strain BJ846.
(B) Number of population doublings achieved by the WS cell strain
BJ846 at the indicated passage levels.
Table 1. Decline in proliferation of the normal human
fibroblast culture 1BR.3 during in vitro cellular ageing
Antibody Assay y-intercept slope x-intercept r2 P
Anti-Ki-67 days 47.5±7.8* - 0.39±0.06* 122±20 0.664 <0.001
APD 59.2±7.8* - 0.79±0.13* 75±10 0.662 <0.001
Anti-PCNA days 23.3±2.5* - 0.22±0.02* 106±11 0.857 <0.001
APD 30.3±2.3* - 0.45±0.04* 67±6 0.886 <0.001
Anti-topo II days 29.2±4.8* - 0.27±0.04* 108±18 0.709 <0.001
APD 37.5±4.7* - 0.54±0.08* 69±8 0.723 <0.001
Details of the regression lines fitted to the data shown in Fig. 4 (normal
fibroblasts). Regression lines were fitted using the least squares method.
Days, number of days in culture. APD, accumulated population doublings. y-
intercept, the fraction of nuclei staining for the indicated antigen at the
initiation of the culture, determined by back-extrapolation of the regression
line to x = 0. Slope, the slope of the regression line generated by the least
squares method. Dimensions of the slopes are: days, fraction positive nuclei
day- 1; APD, fraction positive nuclei APD- 1. x-intercept, the predicted
maximum number of APD achieved by the culture, determined by
extrapolation of the regression line to the x axis when y (the fraction of nuclei
positive for the indicated antigen) = 0. r2, regression coefficient. P,
significance of the slopes. Values are shown ± standard error of the
coefficient. Values marked with an asterisk are multiplied by 100.
A
BThe fraction of cells reacting with the antibody to topo II was
intermediate between Ki-67 and PCNA, although we note that
the assay for topo II-reactive cells is not as sensitive as the
assays for Ki-67 and PCNA.
Since passage number is only a poor indicator of cell ageing,
we have expressed the fraction of cells reacting with each of
the antibodies as a function of the number of accumulated pop-
ulation doublings (Fig. 4D,E and F). By extrapolation of the
regression lines generated for each curve to the horizontal axis,
we obtained the maximum number of APD achieved by the
culture for each antibody used in the assay. Using anti-Ki-67,
the maximum predicted lifespan was 75.0 APD compared with
68.9 APD using anti-topo II and 67.0 APD using anti-PCNA
(Table 1, APD). The small differences between these estimates
arise from the relative sensitivity of the assay with each
antibody. We have included in Table 1 details of the regres-
sion lines generated using the fraction of positive nuclei for
each antibody plotted against time in culture (days). 
Less than 1% of cells in cultures made quiescent by serum
starvation for 48 hours at passage levels 9, 20 and 27 were
positive for each of the antigens Ki-67, PCNA and topo II, con-
firming that expression of these antigens is dependent upon
progression through the cell cycle.
Since expression of these antigens is dependent upon pro-
gression through the cell cycle, then clearly there is a smooth
decline in the fraction of cells that are proliferating as the
culture develops from early to late passage. The rate of decline
in the fraction of positive cells is essentially the same with all
three antibodies. This implies that we are measuring the same
underlying event each time. This is presumably the frequency
of irreversible exit from the cell cycle and here we estimate the
fraction of cells remaining that are cycling.
Essentially all cells were positive throughout the lifespan of
these cultures for the antigens recognised by the antibodies
AAC14, L68A7 and SCL 70. In cultures that were made
quiescent by growth in medium containing low (0.5% v/v)
levels of serum these antigens were still expressed in all cells
(data not shown). Since these antigens are expressed indepen-
dently of the cell cycle, this indicates that the decline in pro-liferative potential of the culture is not accompanied by a sub-
stantial loss of viability during in vitro ageing.
The growth of WS fibroblasts
The growth curve for the WS cell strain (BJ846) is shown in
Fig. 5A. In our hands the culture could achieve only 17 APD
before no further increases in cell number was observed. This
result is consistent with other WS cell strains (Tollefsbol and
Cohen, 1984). The growth rate of the culture measured as the
number of population doublings achieved at each passage by
this culture reveals a decline in the growth rate with each
passage, although the data show considerable scatter (Fig. 5B).
The fraction of cells displaying Ki-67 and PCNA
during the ageing of WS fibroblasts in culture
The data described above using normal fibroblasts indicated
that anti-Ki-67 and anti-PCNA antibodies provided the most
consistent results in the indirect immunofluorescence assay.
With this in mind, and because both anti-Ki-67 and anti-PCNA
are obtainable commercially, we have concentrated on these
two proliferation-dependent antibodies for our assays of WS
fibroblasts. Both antibodies displayed staining patterns indis-
tinguishable from those obtained with normal fibroblasts (data
not shown). The fraction of WS fibroblasts that reacts with
anti-Ki-67 and anti-PCNA at each passage level shows a
gradual decline as with normal fibroblasts (Fig. 6A,B).
Similarly, when plotted against the number of accumulated
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Fig. 6. The fraction of nuclei reacting with anti-Ki-67 and anti-PCNA during the cellular ageing of the WS cell strain BJ846. The fraction of
nuclei reacting with the indicated antibodies were plotted as a function of passage (A,B) and accumulated population doublings (APD; C,D).
Regression lines were fitted using the method of least squares and the details of the fitted lines are given in Table 2.
Table 2. Decline in proliferation of WS fibroblast cultures
during in vitro cellular ageing
Antibody Assay y-intercept slope x-intercept r2 P
Anti-Ki-67 days 30.8±3.5* - 0.54±0.08* 57±6 0.838 <0.001
APD 85.3±3.1* - 4.85±0.67* 18±2 0.868 <0.001
Anti-PCNA days 13.5±2.3* - 0.24±0.06* 57±10 0.687 <0.001
APD 39.6±1.7* - 2.27±0.37* 17±2 0.824 <0.001
Details of the regression lines fitted to the data shown in Fig. 6 (Werners
Syndrome fibroblasts). Regression lines were fitted using the least squares
method. Days, number of days in culture. APD, accumulated population
doublings. y-intercept, the fraction of nuclei staining for the indicated antigen
at the initiation of the culture, determined by back-extrapolation of the
regression line to x = 0. Slope, the slope of the regression line generated by
the least squares method. Dimensions of the slopes are: days, fraction positive
nuclei day- 1; APD, fraction positive nuclei APD- 1. x-intercept, the predicted
maximum number of APD achieved by the culture, determined by
extrapolation of the regression line to the x axis when y (the fraction of nuclei
positive for the indicated antigen) = 0. r2, regression coefficient. P,
significance of the slopes. Values are shown ± standard error of the
coefficient. Values marked with an asterisk are multiplied by 100.
A B
C Dpopulation doublings we observed a gradual decline in the
fraction of cells reacting with each antibody (Fig. 6C,D).
Regression lines were fitted to the data using the method of
least squares (Table 2). The predicted maximum lifespan using
each antibody was determined by extrapolation of the regres-
sion lines. The parameters of these regression lines are shown
in Table 2. Using anti-Ki-67 the maximum predicted lifespan
of WS fibroblasts is estimated at 17.6 APD and using anti-
PCNA, 17.5 APD. We have included in Table 2 details of the
regression lines generated using the fraction of positive nuclei
for each antibody plotted against time in culture (days). 
Essentially all WS fibroblasts were positive for the antigens
recognised by the two proliferation-independent antibodies L6
8A7 and SCL 70 throughout the lifespan of these cultures (data
not shown). Therefore, ageing of WS fibroblasts in culture is
not characterised by a detectable increase in non-metabolising,
moribund cells. 
The data show that WS fibroblast cultures undergo a gradual
decline in the fraction of proliferating cells during serial
passage in the same manner as do normal cells. However, the
rate of decline in the fraction of proliferating cells is acceler-
ated when compared with normal fibroblasts (compare Table
1 with Table 2). It is interesting to note that extrapolation of
the regression lines to the vertical axis (time 0, or the point of
explantation of the culture) for the WS cell strain predicts a
high fraction of cells reacting with either antibody at the
initiation of the culture. For anti-Ki-67 a value of 0.59 wasobtained for normal fibroblasts compared with 0.85 obtained
for WS fibroblasts and for anti-PCNA a value of 0.30 was
obtained for normal fibroblasts compared with 0.40 with WS
fibroblasts. 
Clearly, the rate of decline in the fraction of proliferating
cells in WS cultures is accelerated when compared with the
rate of decline in the fraction of proliferating cells in normal
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A
B
Fig. 7. Comparison of the rate of cellular ageing of normal human
fibroblasts and WS fibroblasts. The fraction of nuclei reacting with
(A) anti-Ki-67 and (B) anti-PCNA, in normal fibroblasts (closed
squares) and WS fibroblasts (open squares) plotted against the
number of accumulated population doublings (APD). Regression
lines were fitted using the method of least squares. fibroblast cultures using either antibody for the assay. To
obtain estimates of the increased rate of decline in the fraction
of proliferating cells between WS and normal fibroblasts
during ageing in vitro, we calculated the ratio of the values of
the slopes derived in the assays plotted against APD for the
antibodies anti-Ki-67 and anti-PCNA. Using anti-Ki-67 a ratio
of 6.14 is obtained (Fs=6.35, Fa [1,27], P=0.02) and using anti-
PCNA a ratio of 5.04 is obtained (Fs=12.44, Fa [1,27], P=0.01).
This is shown graphically in Fig. 7, where we have plotted the
data obtained using each antibody with both normal and WS
fibroblasts on the same axes (Fig. 7A,B).
DISCUSSION
We have demonstrated that the human dermal fibroblast strain
1BR.3 has a finite lifespan. The growth of these cultures is
characterised by a gradual decrease in the fraction of cells that
express each of three cell cycle-regulated antigens. Further-
more, the growth of these cultures is not characterised by a
gradual accumulation of dead cells, since the fraction of cells
expressing each of three cell cycle-independent antigens
remains high and constant during in vitro ageing. The fraction
of cells expressing these antigens remains high and constant in
cultures made quiescent by culture in low concentrations of
serum, confirming that these antigens are expressed indepen-dently of the cell cycle, and in the non-growing cells.
Senescent cultures consist of non-proliferating, mortalized
(Stein et al., 1978; Shall and Stein, 1979) cells that are quite
competent in metabolic activities; the process of cell senes-
cence or mortalization is one of reproductive sterility not cell
death.
We have also confirmed that WS fibroblasts have a finite
lifespan that is markedly reduced when compared with the
lifespan of normal fibroblasts. WS fibroblasts also display a
gradual decrease in the fraction of cells expressing two cell
cycle-regulated antigens. The data clearly show an increase in
the rate of decline in the fraction of cells reacting with either
antibody in the WS cultures compared with the normal fibrob-
last cultures. The ratio of the slopes obtained through assays
of normal and WS cultures using either antibody provide an
estimate of the increase in the frequency of mortalization in
WS cultures compared with normal fibroblasts. Using Ki-67,
a ratio of 6.14 is obtained, and using anti-PCNA, a ratio of 5.04
is obtained. Thus, an indirect immunofluorescence assay of
normal and WS fibroblasts, shows that the foreshortened
lifespan of WS fibroblasts compared with normal fibroblasts is
due to a 5- to 6-fold increase in the rate of loss of proliferat-
ing cells in these cultures during the process of cellular ageing.
One possible explanation for the foreshortened lifespan of WS
fibroblasts compared with normal fibroblasts would be that WS
fibroblasts at an early passage contain a decreased fraction of
proliferating cells, and that these cells exited the proliferative
pool at a rate comparable with that of normal fibroblasts. This
explanation is inconsistent with our data. In addition, it has
been shown that the plating efficiencies of both normal fibrob-
lasts and WS fibroblasts remain stable at levels of above 80-
90% (Salk et al., 1981; Ponten et al., 1983). 
The fraction of cells expressing any one of the three cell
cycle-regulated antigens at any given point in the lifespan of
the culture provides an estimate of the in vitro age of the
culture. Using average estimates obtained using all three anti-
bodies at any given point in the assay increases the reliability
of the estimate of the age of the culture. In addition to allowing
data obtained from different laboratories using different cell
strains to be compared directly, this method may prove useful
in the evaluation of the effects of any treatments intended to
alter the proliferative potential of these cultures, such as
treatment of cultures with 5-azacytosine (Holliday, 1986; Fair-
weather et al., 1987).
Although a growing body of evidence confirms that the
growth of normal mammalian cultures is characterised by a
smooth and gradual decline in the fraction of proliferating
cells, this has not been adequately incorporated into the liter-
ature. It is not uncommon to find reference to the age of
cultures in terms of phases I, II and III as defined by Hayflick
(1965). We suggest that this classification is inappropriate,
since it is inferred that there are intrinsic differences between
young, middle aged and aged cultures. It is now clear that the
difference between cultures at different in vitro ages is the
relative proportions of proliferating and non-proliferating,
post-mitotic cells.
Comparison of WS fibroblasts with normal fibroblasts
revealed that the rate of decline of antibody-reactive cells in
WS cultures was accelerated by 5- to 6-fold. This observation
suggests that the genetic lesion present in WS fibroblasts may
affect the regulation of a biological ‘counter’ gene that in turn
579Proliferation in normal and progeroid fibroblastsaffects the rate of entry into a post-mitotic, non-proliferating
pool of cells. The Werner’s Syndrome phenotype is known to
be due to a recessive mutation in a single autosomal locus
giving rise to a rare disease in the homozygous state (Tollefs-
bol and Cohen, 1984). Presumably, the large foreshortening of
the in vitro lifespan of WS fibroblasts is due to mutation of the
same gene that is responsible for the other features of Werner’s
Syndrome. What then is the relationship between the charac-
teristics of Werner’s Syndrome observed in vivo and the
increase in the rate of irreversible exit from the cell cycle of
WS fibroblasts in vitro? We suggest that those tissues that
show turnover in the adult are dependent upon the prolifera-
tive capacity of their cells to maintain tissue homeostasis.
When the reproductive ability of the cycling cells in the tissue
approaches exhaustion, then that tissue will show significant
deficiency in its characteristic function. Perhaps then, the in
vitro lifespan of cultured cells is a measure of the ability of the
tissue to maintain itself in the intact body. In Werner’s
Syndrome patients, the ability of tissues to maintain them-
selves may be compromised because the cells are losing their
reproductive ability at an increased rate. 
The molecular mechanisms responsible for the loss of pro-
liferative ability of cells as they age in culture remain obscure.
Elucidation of these mechanisms and of the lesion involved in
Werner’s syndrome will greatly enhance our understanding of
cellular ageing and ageing in vivo, as well as providing insight
into cellular transformation and tumorigenesis.
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